Skip to main content
. 2021 Feb 25;15:843–855. doi: 10.2147/DDDT.S293382

Figure 2.

Figure 2

Breviscapine reduced the serum levels of markers of myocardial injury (n = 4 for each group). (A) The levels of cTnI in the four groups. (B) The levels of LDH in the four groups. (C) The levels of CK-MB in the four groups. Data are presented as the mean±standard deviation (SD). *P < 0.05 versus the sham group; #P < 0.05 versus the CME group; &P < 0.05 versus the CME + BE group.

Abbreviations: CME, coronary microembolization; BE, breviscapine; LY, LY294002.